Literature DB >> 11682151

Pretreatment circadian period in free-running blind people may predict the phase angle of entrainment to melatonin.

A J Lewy1, B P Hasler, J S Emens, R L Sack.   

Abstract

To date, we have entrained (synchronized) eight totally blind people with free-running circadian rhythms to a nightly dose of 10 mg of melatonin. Each person entrained at a different phase angle of entrainment (PAE), which is the interval in hours between the time of the melatonin dose and the time of the endogenous melatonin onset. When the PAE was plotted against the pretreatment free-running (i.e. slightly different than 24.0 h) circadian period (tau), the fitted regression line revealed a significant correlation, which is consistent with previous findings on light entrainment of rest-activity rhythms in free-running rodents [Pittendrigh and Daan, J. Comp. Physiol., 106 (1976) 291-331].

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682151     DOI: 10.1016/s0304-3940(01)02261-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

Review 1.  Chronobiological disorders: current and prevalent conditions.

Authors:  Lia R A Bittencourt; Rogerio Santos-Silva; Marco T de Mello; Monica L Andersen; Sergio Tufik
Journal:  J Occup Rehabil       Date:  2010-03

2.  Intrinsic period and light intensity determine the phase relationship between melatonin and sleep in humans.

Authors:  Kenneth P Wright; Claude Gronfier; Jeanne F Duffy; Charles A Czeisler
Journal:  J Biol Rhythms       Date:  2005-04       Impact factor: 3.182

3.  Therapeutics for Circadian Rhythm Sleep Disorders.

Authors:  Ehren R Dodson; Phyllis C Zee
Journal:  Sleep Med Clin       Date:  2010-12

4.  Winter Depression: Integrating mood, circadian rhythms, and the sleep/wake and light/dark cycles into a bio-psycho-social-environmental model.

Authors:  Alfred J Lewy; Jonathan S Emens; Jeannie B Songer; Neelam Sims; Amber L Laurie; Steven C Fiala; Allie L Buti
Journal:  Sleep Med Clin       Date:  2009-06-01

5.  Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline.

Authors:  R Robert Auger; Helen J Burgess; Jonathan S Emens; Ludmila V Deriy; Sherene M Thomas; Katherine M Sharkey
Journal:  J Clin Sleep Med       Date:  2015-10-15       Impact factor: 4.062

Review 6.  Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review.

Authors:  Robert L Sack; Dennis Auckley; R Robert Auger; Mary A Carskadon; Kenneth P Wright; Michael V Vitiello; Irina V Zhdanova
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

Review 7.  Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report.

Authors:  Timothy I Morgenthaler; Teofilo Lee-Chiong; Cathy Alessi; Leah Friedman; R Nisha Aurora; Brian Boehlecke; Terry Brown; Andrew L Chesson; Vishesh Kapur; Rama Maganti; Judith Owens; Jeffrey Pancer; Todd J Swick; Rochelle Zak
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

8.  Timing of sleep and its relationship with the endogenous melatonin rhythm.

Authors:  Tracey L Sletten; Simon Vincenzi; Jennifer R Redman; Steven W Lockley; Shantha M W Rajaratnam
Journal:  Front Neurol       Date:  2010-11-01       Impact factor: 4.003

9.  Clinical applications of melatonin in circadian disorders.

Authors:  Alfred J Lewy
Journal:  Dialogues Clin Neurosci       Date:  2003-12       Impact factor: 5.986

Review 10.  Visual impairment and circadian rhythm disorders.

Authors:  Steven W Lockley; Josephine Arendt; Debra J Skene
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.